Gueyffier, François

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · European Heart Journal

Lipoproteins and Cardiovascular HealthClinical practice guidelines implementation

Cited by 3,162

Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials

Boussageon, R., Bejan-Angoulvant, T., Saadatian-Elahi, M., Lafont, S., Bergeonneau, C., Kassai, B., Erpeldinger, S., Wright, J. M., Gueyffier, F., & Cornu, C. (2011) · BMJ

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 803

Reappraisal of Metformin Efficacy in the Treatment of Type 2 Diabetes: A Meta-Analysis of Randomised Controlled Trials

Boussageon, R., Supper, I., Bejan-Angoulvant, T., Kellou, N., Cucherat, M., Boissel, J.-P., Kassai, B., Moreau, A., Gueyffier, F., & Cornu, C. (2012) · PLoS Medicine

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 266

Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trials

Bejan-Angoulvant, T., Saadatian-Elahi, M., Wright, J. M., Schron, E. B., Lindholm, L. H., Fagard, R., Staessen, J. A., & Gueyffier, F. (2010) · Journal of Hypertension

Blood Pressure and Hypertension StudiesCardiovascular Health and Disease Prevention

Cited by 178

Barriers and Facilitators to the Use of Clinical Decision Support Systems in Primary Care: A Mixed-Methods Systematic Review

Meunier, P.-Y., Raynaud, C., Guimaraes, E., Gueyffier, F., & Letrilliart, L. (2023) · The Annals of Family Medicine

Electronic Health Records SystemsArtificial Intelligence in Healthcare and Education

Cited by 149

Cognitive therapy versus rogerian supportive therapy in borderline personality disorder

Cottraux, J., Note, I. D., Boutitie, F., Milliery, M., Genouihlac, V., Yao, S. N., Note, B., Mollard, E., Bonasse, F., Gaillard, S., et al. (2009) · Psychotherapy and Psychosomatics

Personality Disorders and PsychopathologyPsychotherapy Techniques and Applications

Cited by 99

No benefits of statins for sudden cardiac death prevention in patients with heart failure and reduced ejection fraction: a meta-analysis of randomized controlled trials

Al-Gobari, M., Le, H.-H., Fall, M., Gueyffier, F., & Burnand, B. (2017) · PLOS ONE

Heart Failure Treatment and ManagementLipoproteins and Cardiovascular Health

Cited by 38

How do they add up? The interaction between the placebo and treatment effect: A systematic review

Boussageon, R., Howick, J., Baron, R., Naudet, F., Falissard, B., Harika‐Germaneau, G., Wassouf, I., Gueyffier, F., Jaafari, N., & Blanchard, C. (2022) · British Journal of Clinical Pharmacology

Pain Management and Placebo EffectStatistical Methods in Clinical Trials

Cited by 36

Association between difference in blood pressure reduction and risk of cardiovascular events in a type 2 diabetes population: a meta-regression analysis

Grenet, G., Le, H. H., Bejan-Angoulvant, T., Erpeldinger, S., Boussageon, R., Kassaï, B., Moulin, P., Gueyffier, F., & Cucherat, M. (2019) · Diabetes & Metabolism

Blood Pressure and Hypertension StudiesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 6